Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 48, 2006, Pages 18338-18343

  Liu, Wenhua ^a   Yuen, Eunice Y ^a   Allen, Patrick B ^b   Feng, Jian ^a   Greengard, Paul ^c   Yan, Zhen ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adrenergic receptor; G protein coupled receptor; Microtubule; Neuropsychiatric diseases; RGS4

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 AMINOETHOXYDIPHENYLBORANE; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CALCIUM ION; CIRAZOLINE; CLONIDINE; COLCHICINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DESIPRAMINE; DYNAMIN; G PROTEIN COUPLED RECEPTOR; GUANFACINE; IDAZOXAN; INOSITOL 1,4,5 TRISPHOSPHATE; LATRUNCULIN A; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; PHOSPHOLIPASE C INHIBITOR; PRAZOSIN; RGS PROTEIN; SPINOPHILIN; UO 126; YOHIMBINE;

ANIMAL CELL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN SLICE; DEPRESSION; HYPERACTIVITY; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SCHIZOPHRENIA;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHYSIOLOGY; MICROFILAMENT PROTEINS; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; PHOSPHOLIPASE C; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 33845299158     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0604560103     Document Type: Article

References (41)

1. Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AF (1999) Biol Psychiatry 46:1266-1274.
2. Schramm NL, McDonald MP, Limbird LE (2001) J Neurosci 21:4875-4882.
3. Franowicz JS, Kessler LE, Borja CM, Kobilka BK, Limbird LE, Arnsten AF (2002) J Neurosci 22:8771-8777.
4. Dubini A, Bosc M, Polin V (1997) J Psychopharmacol 11:S17-S23.
5. Charney DS, Redmond DE, Jr (1983) Neuropharmacology 22:1531-1536.
6. Arnsten AF (2004) Psychopharmacology 174:25-31.
7. Russell V, Allie S, Wiggins T (2000) Behav Brain Res 117:69-74.
8. Ninan PT (1999) J Clin Psychiatry 60(Suppl 22):12-17.
9. Hertel P, Fagerquist MV, Svensson TH (1999) Science 286:105-107.
10. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) Pharmacol Rev 51:7-61.
11. Jentsch JD, Roth RH (1999) Neuropsychopharmacology 20:201-225.
12. Tsai G, Coyle JT (2002) Annu Rev Pharmacol Toxicol 42:165-179.
13. Manabe T, Wyllie DJ, Perkel DJ, Nicoll RA (1993) J Neurophysiol 70:1451-1459.
14. Harrison JK, Pearson WR, Lynch KR (1991) Trends Pharmacol Sci 12:62-67.
15. Wenthold RJ, Prybylowski K, Standley S, Sans N, Petralia RS (2003) Annu Rev Pharmacol Toxicol 43:335-358.
16. Yuen EY, Jiang Q, Chen P, Gu Z, Feng J, Yan Z (2005) J Neurosci 25: 5488-5501.
17. Yuen EY, Jiang Q, Feng J, Yan Z (2005) J Biol Chem 280:29420-29427.
18. Vries LD, Zheng B, Fischer T, Elenko E, Farquhar MG (2000) Annu Rev Pharmacol Toxicol 40:235-271.
19. Li Y, Hashim S, Anand-Srivastava MB (2005) Cardiovasc Res 66:503-511.
20. Diverse-Pierluissi MA, Fischer T, Jordan JD, Schiff M, Ortiz DF, Farquhar MG, De Vries L (1999) J Biol Chem 274:14490-14494.
21. Ingi T, Krumins AM, Chidiac P, Brothers GM, Chung S, Snow BE, Barnes CA, Lanahan AA, Siderovski DP, Ross EM, et al. (1998) J Neurosci 18:7178-7188.
22. Erdely HA, Lahti RA, Lopez MB, Myers CS, Roberts RC, Tamminga CA, Vogel MW (2004) Eur J Neurosci 19:3125-3128.
23. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, BK T, Ferrell RE, Middleton FA, et al. (2002) Hum Mol Genet 11:1373-1380.
24. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, McCreadie RG, Buckland P, Sharkey V, Chowdari KV, Zammit S, et al. (2004) Biol Psychiatry 55:192-195.
25. Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP (2004) Am J Med Genet Neuropsychiatr Genet 125B:50-53.
26. Harrison PJ, Owen MJ (2003) Lancet 361:417-419.
27. Smith FD, Oxford GS, Milgram SL (1999) J Biol Chem 274:19894-19900.
28. Richman JG, Brady AE, Wang Q, Hensel JL, Colbran RJ, Limbird LE (2001) J Biol Chem 276:15003-15008.
29. Wang X, Zeng W, Soyombo AA, Tang W, Ross EM, Barnes AP, Milgram SL, Penninger JM, Allen PB, Greengard P, et al. (2005) Nat Cell Biol 7:405-411.
30. Feng J, Yan Z, Ferreira AB, Tomizawa K, Liauw JA, Zhuo M, Allen PB, Ouimet CC, Greengard P (2000) Proc Natl Acad Sci USA 97:9287-9292.
31. Gerber U (2002) Neuropharmacology 42:587-592.
32. Wang X, Zhong P, Gu Z, Yan Z (2003) J Neurosci 23:9852-9861.
33. Hallett PJ, Spoelgen R, Hyman BT, Standaert DG, Dunah AW (2006) J Neurosci 26:4690-4700.
34. Berman DM, Wilkie TM, Gilman AG (1996) Cell 86:445-452.
35. Zheng B, De Vries L, Gist Farquhar M (1999) Trends Biochem Sci 24:411-414.
36. Huang C, Hepler JR, Gilman AG, Mumby SM (1997) Proc Natl Acad Sci USA 94:6159-6163.
37. Hepler JR, Berman DM, Gilman AG, Kozasa T (1997) Proc Natl Acad Sci USA 94:428-432.
38. Yan Y, Chi PP, Bourne HR (1997) J Biol Chem 272:11924-11927.
39. Zeng W, Xu X, Popov S, Mukhopadhyay S, Chidiac P, Swistok J, Danho W, Yagaloff KA, Fisher SL, Ross EM, et al. (1998) J Biol Chem 273:34687-34690.
40. Xu X, Zeng W, Popov S, Berman DM, Davignon I, Yu K, Yowe D, Offermanns S, Muallem S, Wilkie TM (1999) J Biol Chem 274:3549-3556.
41. Wang Q, Zhao J, Brady AE, Feng J, Allen PB, Lefkowitz RJ, Greengard P, Limbird LE (2004) Science 304:1940-1944.